This inventor holds 35 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Nucleic Acid Analysis. Top assignees: Hitachi, Ltd., Hitachi-High-Technologies Corporation, Hitachi High-Tech Corporation. Active years: 2000-2023.
Location History:
- Mito, JP (2000 - 2018)
- Tokyo, JP (2014 - 2023)
Company Filing History:
15 out of 42,713 
12 out of 2,874 
7 out of 1,363 
Years Active: 2000-2023
Areas of Expertise:
Title: The Innovations of Muneo Maeshima
Introduction
Muneo Maeshima is an accomplished inventor based in Mito, Japan, with an impressive portfolio of 35 patents. His work primarily focuses on advancements in bacterial identification and antimicrobial susceptibility testing, showcasing a dedication to improving medical technology and diagnostics.
Latest Patents
Among his notable patents is a groundbreaking **Test Device** that offers a swift and accurate method of determining bacterial identification and antimicrobial susceptibility. This invention involves microscopic observation techniques to monitor the division state of bacteria on a culture plate. The device interprets the shape, number, and area of the bacteria, assessing growth from the induction phase to the logarithmic phase. With the aid of graphical representations of time-dependent changes, it delivers real-time results on bacterial proliferation and antimicrobial susceptibility.
In conjunction with this, the **Test Apparatus** patent enhances the accuracy of bacterial identification and antimicrobial testing. By integrating traditional turbidity assessments with innovative microscopic observations, it monitors the shapes and numbers of bacteria to determine growth phases, ensuring precise test results for clinicians.
Career Highlights
Muneo Maeshima has contributed his expertise to esteemed companies such as Hitachi, Ltd. and Hitachi High-Technologies Corporation. His experiences in these prominent organizations have allowed him to refine his skills and expand his contributions to the field of microbiology and diagnostics.
Collaborations
Throughout his career, Maeshima has collaborated with notable colleagues, including Shigeru Matsui and Kazuo Takeda. These partnerships have enriched his work, fostering innovation and leading to the development of cutting-edge technologies in bacterial research.
Conclusion
Muneo Maeshima exemplifies the spirit of innovation in the realm of medical technology. His pioneering patents and collaborative efforts underline his commitment to enhancing healthcare diagnostics. As the field of microbiology continues to evolve, Maeshima’s contributions will undoubtedly play a significant role in shaping its future.